Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @C_I_F_C_F
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @C_I_F_C_F
-
We will be sharing more information about
#bladdercancer and the global impact throughout the day. A healthier, brighter future for everyone is possible#WorldCancerDay
#iamandiwill
#bladdercancerpic.twitter.com/qRpZd7KbbQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A healthier, brighter future for everyone is possible.
#WorldCancerDay
#iamandiwill
#bladdercancer https://www.instagram.com/p/B8IpcsJgaeo/?igshid=ua0ggsn7muti …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only. https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/118610-pathological-downstaging-following-radical-cystectomy-for-muscle-invasive-bladder-cancer-survival-outcomes-in-the-setting-of-neoadjuvant-chemotherapy-versus-transurethral-resection-only.html … via
@urotoday#bladdercancerpic.twitter.com/KOrzkNaePn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Crush It For Curtis Foundation proslijedio/la je Tweet
Young investigators can now apply for $600,000 in fellowship and award opportunities.
#SITCFellowship Learn more and apply at http://sitcancer.org/fellowships pic.twitter.com/8qcHrvnz4W
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Down-regulation of CIT can inhibit the growth of human bladder cancer cells. https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/118602-down-regulation-of-cit-can-inhibit-the-growth-of-human-bladder-cancer-cells.html … via
@urotoday#bladdercancerpic.twitter.com/9Ch2XdFhJ5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
via
@urotoday Advancements in Treating NMIBC: Pembrolizumab FDA-Approved for High-Risk Non-Muscle Invasive Bladder Cancer https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/118601-pembrolizumab-fda-approved-for-high-risk-non-muscle-invasive-bladder-cancer.html …#bladdercancer#NMIBCpic.twitter.com/TnHfTfnJ1h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SIT of Cancer | Improves cancer patient outcomes by advancing the science, development, & application of cancer immunology & immunotherapy through their core values of integration, innovation, translation & leadership in the field: consider joining: https://www.sitcancer.org/membership#.XjBi2px26tA.twitter …pic.twitter.com/DNBB1fjr50
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gender Disparities in Clinical Outcomes after Cystectomy - Expert Commentary https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/118029-gender-disparities-in-clinical-outcomes-after-cystectomy-expert-commentary.html … via
@urotoday#bladdercancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review. https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/118480-biomarkers-for-bladder-cancer-diagnosis-and-surveillance-a-comprehensive-review.html … via
@urotoday#bladdercancerpic.twitter.com/CWIg00PRqV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Enfortumab Vedotin-ejfv for Previously Treated Advanced Urothelial Cancer - The ASCO Post
@ASCO https://www.ascopost.com/issues/january-25-2020/enfortumab-vedotin-ejfv-for-previously-treated-advanced-urothelial-cancer/?utm_source=TAP+ETOC+Emails+9.12.2019&utm_medium=Email&utm_campaign=TAP+ETOC+Emails+9.12.2019&email=b4ad28c01984421efe0ae3454106e351f6597aa0f1b81a2a039c0c9595a03511#.Xixw0uD7RCU.twitter …#bladdercancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives. https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/118359-orthotopic-neobladder-reconstruction-patient-selection-and-perspectives.html … via
@urotoday#bladdercancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Advanced Bladder Cancer Clinic: Are you Ready? - Neal Shore https://www.urotoday.com/video-lectures/lugpa-2019/video/mediaitem/1613-advanced-bladder-cancer-clinic-are-you-ready-neal-shore.html?utm_source=newsletter_7377&utm_medium=email&utm_campaign=experts-discussing-quality-clinical-outcomes … via
@urotoday#bladdercancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32562#.XiPvj9nr59o.twitter …
#bladdercancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Crush It For Curtis Foundation proslijedio/la je Tweet
Patients are interested in research but don’t know how to get involved, while researchers are spending valuable time and resources trying to find patients for their studies. There is a very real gap between these two groups — one that we aim to bridge.https://hubs.ly/H0mxYm00
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Understanding Immunotherapy, how it works, and types of
#Immunotherapy - Learn more about Immunotherapy treatment and read the patient resource guide by visiting http://cifcf.org#bladdercancer#checkpointinhibitor#PDL1pic.twitter.com/xPVsVf8l9sHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.